12 May 1995 Low-level laser therapy for Peyronie's disease
Author Affiliations +
We are reporting the preliminary results of a nonrandomized trial using a low-level gallium- aluminum-arsenide (GaAlAs) laser at a wavelength of 830 nm (Microlight 830, Lasermedics, Inc., Stafford, TX) to treat patients with symptomatic Peyronie's disease. All patients entered into the study had disease consisting of a well-defined fibrous plaque causing pain and/or curvature of the penile shaft on erection that interfered with satisfactory sexual intercourse. Treatment has consisted of 30 mW administered over a duty cycle of 100 seconds (3 J) beginning at the base of the penis and extending to the coronal sulcus over the dorsum of the penis at 0.5 cm intervals. An additional duty cycle of 100 seconds was delivered to each 0.5 cm of palpable plaque. The ability of the therapy to reduce the size of the fibrous plaque, the severity of the penile curvature, and the severity of pain associated with penile erection and the treatment's effect on the patient's quality of life were assessed for each patient at completion of therapy and 6 weeks later.
© (1995) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Douglas E. Johnson, Douglas E. Johnson, John E. Jr. Bertini, John E. Jr. Bertini, James M. Harris, James M. Harris, Janet H. Hawkins, Janet H. Hawkins, } "Low-level laser therapy for Peyronie's disease", Proc. SPIE 2395, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems V, (12 May 1995); doi: 10.1117/12.209091; https://doi.org/10.1117/12.209091


Back to Top